- Bank Hapoalim reported a net income of 2.24 billion shekels for Q2 2024.
- This marks a 17% increase compared to last year, when net income was 1.92 billion shekels.
- Net interest income for the quarter was 4.38 billion shekels, up by 2.1% year-over-year.
- There was a recovery of loan losses amounting to 49 million shekels.
- This is significant compared to last year’s provision of 579 million shekels for loan losses.
- Market analysts provided 5 buy ratings and 1 hold rating for the bank’s stock, with no sell ratings.
A look at Bank Hapoalim Bm Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 5 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 4.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Bank Hapoalim B.M. is positioned for a positive long-term outlook, as indicated by its Smartkarma Smart Scores. With strong scores in Value, Dividend, Growth, and Momentum, the bank is showing promise across key factors. A standout score of 5 in Resilience further cements its stability and ability to weather market fluctuations. The bank, known for attracting deposits and providing a range of banking services globally, is demonstrating solid fundamentals that bode well for its future performance.
Bank Hapoalim B.M., a renowned banking institution offering a diverse array of services in Israel and internationally, is backed by robust scores across critical areas. Its emphasis on value, dividends, growth, and momentum underscores its potential for sustained success in the long run. With a resilient score of 5, the bank showcases its ability to navigate challenges effectively. Investors may find Bank Hapoalim B.M. an attractive prospect given its strong standing across various key indicators.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
